首页
产品目录
分子砌块
按官能团
酯类
(5-甲基-2-氧代-1,3-二氧杂环戊-4-基)甲基2-乙氧基-1-((2'-(4-乙基-5-氧代-4,5-二氢-1,2,4-噁二唑-3-基)-[1,1'-联苯]-4-基)甲基)-1H-苯并[d]咪唑-7-羧酸酯
(5-甲基-2-氧代-1,3-二氧杂环戊-4-基)甲基2-乙氧基-1-((2'-(4-乙基-5-氧代-4,5-二氢-1,2,4-噁二唑-3-基)-[1,1'-联苯]-4-基)甲基)-1H-苯并[d]咪唑-7-羧酸酯
(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2'-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
产品编号 :
Cas No. :
| 包装规格 |
纯度 |
目录价 |
会员专享价 |
库存 |
数量 |
| 1mg |
97% |
|
|
询价 |
|
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No. |
1417576-01-2 |
中文名称 |
(5-甲基-2-氧代-1,3-二氧杂环戊-4-基)甲基2-乙氧基-1-((2'-(4-乙基-5-氧代-4,5-二氢-1,2,4-噁二唑-3-基)-[1,1'-联苯]-4-基)甲基)-1H-苯并[d]咪唑-7-羧酸酯 |
英文名称 |
(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2'-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate |
别名 |
N-Ethyl Azilsartan Medoxomil;2-Ethoxy-1-[[2'-(4-ethyl-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl ester;Azilsartan Impurity 49;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate;Azilsartan Medoxomil N-Ethyl;1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(4-ethyl-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester;Azilsartan Impurity 97;methyl 2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)(methyl)amino)-4-nitrobenzoate |
标准英文名 |
(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2'-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate |
MDL No. |
MFCD35145799 |
分子式 |
C32H28N4O8 |
分子量 |
596.60
|
精确分子量 |
596.19
|
SMILES |
CCOC1=NC2=C(C(C(=O)OCC3=C(C)OC(=O)O3)=CC=C2)N1CC1=CC=C(C2=CC=CC=C2C2=NOC(=O)N2CC)C=C1 |
标准SMILES |
CC1OC(=O)OC=1COC(=O)C1=CC=CC2N=C(OCC)N(CC3C=CC(=CC=3)C3=CC=CC=C3C3=NOC(=O)N3CC)C=21 |
InChIKey |
MKIYPVLTVAXBIW-UHFFFAOYSA-N |